Literature DB >> 17693604

Protective effect of A at position - 168 in the type III promoter of the MHCIITA gene in systemic lupus erythematosus.

Hiroshi Okamoto, Hirotaka Kaneko, Chihiro Terai, Naoyuki Kamatani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17693604      PMCID： PMC1955137          DOI： 10.1136/ard.2006.066142

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  10 in total

Review 1.  Genetic control of MHC class II expression.

Authors:  Jenny Pan-Yun Ting; John Trowsdale
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

2.  MHC2TA is associated with rheumatoid arthritis in Japanese patients.

Authors:  Noriko Iikuni; Katsunori Ikari; Shigeki Momohara; Taisuke Tomatsu; Masako Hara; Hisashi Yamanaka; Hiroshi Okamoto; Naoyuki Kamatani
Journal:  Ann Rheum Dis       Date:  2006-11-07       Impact factor: 19.103

3.  Enhanced major histocompatibility complex (MHC) class II antigen expression in lupus nephritis.

Authors:  P L Cheah; L M Looi; C T Chua; S F Yap; S Fleming
Journal:  Malays J Pathol       Date:  1997-12       Impact factor: 0.656

4.  A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production.

Authors:  T Gourley; S Roys; N W Lukacs; S L Kunkel; R A Flavell; C H Chang
Journal:  Immunity       Date:  1999-03       Impact factor: 31.745

5.  MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction.

Authors:  Maria Swanberg; Olle Lidman; Leonid Padyukov; Per Eriksson; Eva Akesson; Maja Jagodic; Anna Lobell; Mohsen Khademi; Ola Börjesson; Cecilia M Lindgren; Pia Lundman; Anthony J Brookes; Juha Kere; Holger Luthman; Lars Alfredsson; Jan Hillert; Lars Klareskog; Anders Hamsten; Fredrik Piehl; Tomas Olsson
Journal:  Nat Genet       Date:  2005-04-10       Impact factor: 38.330

6.  Promoter polymorphism rs3087456 in the MHC class II transactivator gene is not associated with susceptibility for selected autoimmune diseases in German patient groups.

Authors:  D A Akkad; P Jagiello; P Szyld; R Goedde; S Wieczorek; W L Gross; J T Epplen
Journal:  Int J Immunogenet       Date:  2006-02       Impact factor: 1.466

7.  Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population.

Authors:  K Ikari; S Momohara; E Inoue; T Tomatsu; M Hara; H Yamanaka; N Kamatani
Journal:  Rheumatology (Oxford)       Date:  2006-05-11       Impact factor: 7.580

8.  The 1982 revised criteria for the classification of systemic lupus erythematosus.

Authors:  E M Tan; A S Cohen; J F Fries; A T Masi; D J McShane; N F Rothfield; J G Schaller; N Talal; R J Winchester
Journal:  Arthritis Rheum       Date:  1982-11

9.  Up-regulated MHC-class II expression and gamma-IFN and soluble IL-2R in lupus nephritis.

Authors:  H Yokoyama; T Takabatake; M Takaeda; T Wada; T Naito; K Ikeda; S Goshima; K Takasawa; N Tomosugi; K Kobayashi
Journal:  Kidney Int       Date:  1992-09       Impact factor: 10.612

10.  The MHC2TA -168A>G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients.

Authors:  Babak Yazdani-Biuki; Kerstin Brickmann; Klaus Wohlfahrt; Thomas Mueller; Winfried März; Wilfried Renner; Manuela Gutjahr; Uwe Langsenlehner; Peter Krippl; Thomas C Wascher; Bernhard Paulweber; Winfried Graninger; Hans-Peter Brezinschek
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156
  10 in total
  2 in total

1.  The rs4774 CIITA missense variant is associated with risk of systemic lupus erythematosus.

Authors:  P G Bronson; B A Goldstein; P P Ramsay; K B Beckman; J A Noble; J A Lane; M F Seldin; J A Kelly; J B Harley; K L Moser; P M Gaffney; T W Behrens; L A Criswell; L F Barcellos
Journal:  Genes Immun       Date:  2011-05-26       Impact factor: 2.676

2.  Effects of C2ta genetic polymorphisms on MHC class II expression and autoimmune diseases.

Authors:  Anthony C Y Yau; Fredrik Piehl; Tomas Olsson; Rikard Holmdahl
Journal:  Immunology       Date:  2016-12-22       Impact factor: 7.397
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.